Director, Dx Strategy & Commercialization

Job Description: At InterVenn Biosciences, our mission is to advance a new era of personalized medicine by decoding the human glycoproteome – glycosylated proteins which are responsible for driving protein function – revealing a rich source of biological insights that has the potential to significantly improve drug development and patient outcomes. We have pioneered an AI powered, high-throughput biomarker discovery platform called GlycoVision™, enabling a detailed and quantitative view into an untapped layer of biology at a clinically meaningful scale for the first time in history. We are seeking a high-impact leader to bridge the gap between our breakthrough glycoproteomics platform and the clinical market. You are a strategic thinker who isn't afraid to open Excel or get into the field to meet a Key Opinion Leader (KOL). You thrive in the ambiguity of a small company and enjoy the challenge of commercializing complex science that the world hasn't seen before. As the Director, Dx Strategy & Commercialization, you will own the end-to-end lifecycle for our Laboratory Developed Test(s) (LDTs). You will be responsible for proving their clinical value, securing reimbursement, and architecting the roadmap for our future diagnostics pipeline.

Commercial Execution & Market Access: Clinical Utility & Evidence: Work with Data Science group to define and oversee the execution of clinical validation and clinical utility of tests to payers and providers. Work with executive management and key leadership to recruit key opinion leaders and other sites to support clinical studies. Payment Strategy: Develop and execute the pathway for reimbursement, including technical assessment submissions; manage relationships with MACs and private payers; identify and secure revenue-driving initiatives. Go-to-Market (GTM): Design and drive commercial launch plans, including branding, physician education programs, and initial sales support needs. Partnerships: Identify and build strategic relationships with health systems, labs, and pharma partners to expand test adoption. Strategic Planning & Product PipelineR&D Liaison: Work closely with the R&D team to translate technical capabilities into "market-ready" and commercially successful diagnostic products. Market Intelligence: Conduct deep-dive analyses on competitive landscapes, white space opportunities, and stay abreast of evolving regulatory requirements (e.g., FDA oversight of LDTs).Financial Modeling: Build robust and practically-focused TAM/SAM/SOM models and five-year P&L projections for current and future assays to guide board-level investment decisions. Lead validation of critical model assumptions with major stake holders: key opinion leaders, executive management and the Board of Directors.

Operational Leadership: Define Key Performance Indicators (KPIs) for commercial success. Lead the company in implementation of strategic and tactical elements that drive success. Report on progress to the executive leadership team and the Board of Directors. Work cross functionally with QA/RA, legal, lab operations and other teams to ensure commercialization plans activities are compliant and sustainable. Skills and Qualification Requirements:

• A genuine desire to impact patient lives and contribute to the greater scientific community
• Ability to speak "proteomics"—you must be able to explain the value of post-translational modifications and biomarkers to both PhDs/MDs and payers.
• Proven ability to build complex ROI models and P&L forecasts.
• Deep understanding of the CLIA/CAP environment and the shifting FDA landscape regarding IVDs and LDTs.7–10+ years in the molecular diagnostics or precision medicine space, with specific experience in LDT commercialization.
• Bachelor's degree in life sciences required; MBA, PhD, or MS is highly preferred.
• Compensation
• Range $175,000-$220,000